Variable | Total | Malignant tumor (n = 224) | Benign tumor (n = 534) | P-value |
---|---|---|---|---|
Normal information | ||||
Age | 41.97 ± 16.16 | 50.50 ± 14.09 | 38.39 ± 15.64 | < 0.001 |
BMI | 22.46 ± 2.45 | 22.60 ± 2.47 | 22.40 ± 2.44 | 0.257 |
Course of disease (days) | 307.72 ± 740.25 | 149.49 ± 464.49 | 374.09 ± 820.40 | < 0.001 |
General condition |  |  |  | < 0.001 |
good(Â 1Â ) | 41(5.41%) | 5(2.23%) | 36(6.74%) | Â |
medium(Â 2Â ) | 713(94.06%) | 215(95.98%) | 498(93.26%) | Â |
cachexia (Â 3Â ) | 4(0.53%) | 4(1.79%) | - | Â |
Imaging indicators | ||||
Mass size (BUS) | 85.58 ± 51.97 | 103.10 ± 46.04 | 78.24 ± 52.59 | < 0.001 |
Mass size (MR/CT) | 89.25 ± 65.57 | 105.67 ± 62.45 | 82.36 ± 65.68 | < 0.001 |
Mass locations (BUS) | Â | Â | Â | 0.284 |
Unilateral ( 1 ) | 682(89.97%) | 197(87.95%) | 485(90.82%) |  |
Bilateral ( 2 ) | 76(10.03%) | 27(12.05%) | 49(9.18%) |  |
Mass locations (MR/CT) | Â | Â | Â | 1 |
Unilateral ( 1 ) | 647(85.36%) | 191(85.27% ) | 456(85.39%) |  |
Bilateral ( 2 ) | 111(14.64%) | 33(14.73%) | 78(14.61%) |  |
Post-menopause |  |  |  | < 0.001 |
No ( 1 ) | 461(60.82%) | 79(35.27%) | 382(71.54%) |  |
Yes ( 2 ) | 297(39.18%) | 145(64.73%) | 152(28.46%) |  |
Ascites (palpation) |  |  |  | < 0.001 |
Yes ( 1 ) | 39(5.15%) | 33(14.73%) | 6(1.12%) |  |
No ( 2 ) | 719(94.85%) | 191(85.27%) | 528(98.88%) |  |
Tumor markers | Â | Â | Â | Â |
HE4 (pmol/L) | 212.10 ± 537.10 | 515.23 ± 893.93 | 84.95 ± 143.39 | < 0.001 |
CA125 (U/mL) | 332.66 ± 1120.92 | 971.25 ± 1911.41 | 64.79 ± 112.53 | < 0.001 |
ROMA_before | 25.52 ± 28.60 | 53.86 ± 36.55 | 13.64 ± 11.13 | < 0.001 |
ROMA_after | 30.65 ± 28.30 | 60.85 ± 33.65 | 17.98 ± 10.92 | < 0.001 |
Red blood cell related indicators | ||||
RBC | 4.18 ± 0.43 | 4.06 ± 0.47 | 4.24 ± 0.40 | < 0.001 |
HGB | 121.82 ± 14.68 | 116.47 ± 15.76 | 124.07 ± 13.60 | < 0.001 |
HCT | 37.51 ± 3.98 | 36.19 ± 4.42 | 38.06 ± 3.65 | < 0.001 |
RDW | 13.12 ± 1.62 | 13.37 ± 1.97 | 13.01 ± 1.44 | < 0.001 |
MCV | 89.88 ± 6.85 | 89.39 ± 6.68 | 90.08 ± 6.91 | 0.016 |
MCH | 29.18 ± 2.76 | 28.75 ± 2.60 | 29.36 ± 2.80 | < 0.001 |
MCHC | 324.28 ± 12.12 | 321.37 ± 11.23 | 325.50 ± 12.28 | < 0.001 |
White blood cell related indicators | ||||
WBC | 6.45 ± 2.17 | 7.03 ± 2.67 | 6.20 ± 1.87 | < 0.001 |
NE% | 60.69 ± 11.26 | 67.76 ± 11.00 | 57.73 ± 9.98 | < 0.001 |
NE | 4.04 ± 2.06 | 4.95 ± 2.55 | 3.66 ± 1.68 | < 0.001 |
MO% | 6.50 ± 1.94 | 6.82 ± 2.07 | 6.37 ± 1.86 | 0.006 |
MO | 0.41 ± 0.16 | 0.46 ± 0.19 | 0.38 ± 0.13 | < 0.001 |
BA% | 0.43 ± 0.24 | 0.40 ± 0.23 | 0.44 ± 0.24 | 0.051 |
BA | 0.03 ± 0.01 | 0.03 ± 0.02 | 0.03 ± 0.01 | 0.994 |
EO% | 2.20 ± 1.89 | 1.91 ± 2.00 | 2.32 ± 1.84 | < 0.001 |
EO | 0.13 ± 0.12 | 0.12 ± 0.12 | 0.14 ± 0.12 | 0.005 |
LY | 1.83 ± 0.65 | 1.46 ± 0.55 | 1.99 ± 0.63 | < 0.001 |
LY% | 30.10 ± 10.22 | 23.01 ± 9.94 | 33.08 ± 8.78 | < 0.001 |
Platelet related indicators | ||||
PLT | 247.02 ± 83.61 | 288.03 ± 112.71 | 229.82 ± 60.08 | < 0.001 |
MPV | 10.51 ± 1.35 | 10.22 ± 1.35 | 10.64 ± 1.34 | < 0.001 |